Healing and feeding the world
In the life sciences sector, companies are working on both medical and agricultural products and services.
The Park is currently home to 34 biomedical companies working on a wide range of products and technologies spanning disease prediction and prevention to diagnostics, treatment and patient monitoring. This number will increase significantly when the new 40,000 sq ft BioHub opens next year.
- 12 companies are involved in the research and development of therapeutics. This includes small molecule drug discovery, biologics, immuno-therapies and generics across multiple disease areas
- 7 companies specialise in medical products including non-invasive diagnostics and wearables
- 14 companies are developing platform technologies or products and services for research scientists. These include suppliers of antibodies, informatics and data services, regulatory and technical consulting
In the agri-tech sector, the Park is home to companies working on crop protection products for professional farmers and growers.
Linguamatics Highlights 2018 Achievements and Advances NLP Text Analytics Market Leadership
12 Dec 2018
TWEET by @AstraZeneca
While progress has been made, there is still unmet medical need for people with chronic lymphocytic #leukaemia (CLL). For many, the disease may return even after successful treatment. We’re committed to advancing the science to transform cancer care for these patients. #EHA24 pic.twitter.com/csEGUUf7Ym